Amgen owes $20.2 million in antibody patent lawsuit, US jury says
Amgen owes $20.2 million in antibody patent lawsuit, US jury says Reuters
Amgen owes $20.2 million in antibody patent lawsuit, US jury says Reuters
Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.